The pathway construction for biosynthesis of aromatic amino acids in Escherichia coli is atypical of the phylogenetic subdivision of gram-negative bacteria to which it belongs (R. A. Jensen, Mol. Biol. Evol. 2:92-108, 1985). Related organisms possess second pathways to phenylalanine and tyrosine which depend upon the expression of a monofunctional chorismate mutase (CM-F) and cyclohexadienyl dehydratase (CDT). Some enteric bacteria, unlike E. coli, possess either CM-F or CDT. These essentially cryptic remnants of an ancestral pathway can be a latent source of biochemical potential under certain conditions. As one example of advantageous biochemical potential, the presence of CM-F in SalmoneUa typhimurium increases the capacity for prephenate accumulation in a tyrA auxotroph. We report the finding that a significant fraction of the latter prephenate is transaminated to L-arogenate. The tyrA19 mutant is now the organism of choice for isolation of L-arogenate, uncomplicated by the presence of other cyclohexadienyl products coaccumulated by a Neurospora crassa mutant that had previously served as the prime biological source of L-arogenate. Prephenate aminotransferase activity was not conferred by a discrete enzyme, but rather was found to be synonymous with the combined activities of aspartate aminotransferase (aspC), aromatic aminotransferase (lyrB), and branchedchain aminotransferase (ilvE). This conclusion was confirmed by results obtained with combinations of aspC-, tyrB-, and ilvE-deficient mutations in E. coli. An example of disadvantageous biochemical potential is the presence of a cryptic CDT in Klebsiella pneumoniae, where a mutant carrying multiple enzyme blocks is the standard organism used for accumulation and isolation of chorismate. The anomalous presence of CDT accounts for leakiness in its growth requirement for phenylalanine.
Chorismate and prephenate are universal precursors of L-tyrosine (Tyr) and L-phenylalanine (Phe) in both microorganisms and plants (24) . In higher plants L-arogenate (25) , derived from prephenate by transamination, is the immediate precursor of Tyr and Phe (17) . In contrast, Escherichia coli utilizes phenylpyruvate and 4-hydroxyphenylpyruvate as the immediate precursors of Phe and Tyr, respectively. However, the E. coli pathway construction is not typical of the phylogenetic subdivision of gram-negative bacteria to which it belongs. Members of this subdivision generally possess dual enzymatic routes to Phe and Tyr, a pathway construction typified by that present in Pseudomonas aeruginosa (3, 7, 16) . In such dual-pathway systems Tyr formation may proceed from either 4-hydroxyphenylpyruvate or L-arogenate, while Phe formation may derive directly from either phenylpyruvate or L-arogenate (Fig. 1) .
It has recently become recognized that within the closely related genera of enteric bacteria, considerable diversity exists for pathway construction of aromatic amino acid biosynthesis (2, (4) (5) (6) . Thus, Serratia and Erwinia species possess a complete dual-pathway arrangement, whereas other genera possess only chorismate mutase F (CM-F) or cyclohexadienyl dehydratase (CDT), evolutionary remnants of the L-arogenate flow routes that have been discarded by E. coli (16) . Before this study, it had not been established whether prephenate aminotransferase in enteric bacteria is a discrete enzyme or whether activity is fortuitously conferred by multiple aminotransferase enzymes.
Auxotrophic mutants are used for the microbiological accumulation of chorismate, prephenate, and L-arogenate ( Fig. 1) . Chorismate is isolated from Klebsiella pneumoniae (11) . Prephenate is prepared from either Salmonella typhimurium (12) or Neurospora crassa (26) . L-Arogenate is isolated from N. crassa (19, 25, 26) . In this paper we show that the S. typhimurium tyrAJ9 mutant is a more efficient source of L-arogenate than is N. crassa ATCC 36373. The biotechnological impact of the presence of prephenate aminotransferase, CM-F, or CDT upon intermediate accumulation in auxotrophic Salmonella and Klebsiella mutants is elucidated. An evolutionary framework exists within the E. coli genealogy for selection of organisms having pathway variations most appropriate for desired biochemical alterations aimed at biotechnological goals.
MATERIALS AND METHODS
Microbial strains. The S. typhimurium tyrA19 mutant (22) Growth regimens. Previously described growth protocols were followed for E. coli W ATCC 9637 (20) and K. pneumoniae ATCC 25304 (21) . Aminotransferase-deficient mutants of E. coli (DG27, DG30, DG34, and DG44) were grown in a minimal medium with supplementation as described previously (14) . S. typhimurium strains were grown in minimal salts medium (23) as described by Dayan and Sprinson (12 15-s bursts of energy at an intensity of 100 to 110 W; each burst was followed by 2 min of cooling. After ultracentrifugation at 150,000 x g at 4°C for 60 min, the extracts were dialyzed against the extraction buffer (three changes of 1 liter each).
Measurement of intracellular pool sizes of prephenate and L-arogenate. Approximately 500 mg (wet weight) of sedimented cells of S. typhimurium were harvested by centrifugation after 6 h of growth, resuspended in 20 mM potassium phosphate buffer (pH 7.5), sonicated, and centrifuged (as above), and concentrations of prephenate and L-arogenate in a crude extract preparation containing 11.6 mg of protein per ml were determined.
Determinations of prephenate and L-arogenate concentrations. The prephenate concentration was determined after the quantitative conversion of prephenate to phenylpyruvate by addition of 0.1 ml of 1 M HCI to 0.1-ml samples of prephenate, followed by incubation at 37°C for 10 min. A 0.8-ml amount of 2.5 M NaOH was added, and the A320 was measured. The phenylpyruvate concentration was calculated by using a molar extinction coefficient of 17,500 (11) .
L-Arogenate was identified by high-pressure liquid chromatography (HPLC) separation of the o-phthalaldehyde derivative on a C-18 ODS column (4.6 by 250 mm; Alltech).
Experimental samples of L-arogenate were shown to elute with the same retention time as authentic L-arogenate.
Following treatment of 0.1-ml samples with 0.1 ml of 1 M HCI at 37°C for 10 min, no peak was visualized in the position expected for L-arogenate and a new peak appeared which corresponded to Phe, the nonenzymatic acidification product of L-arogenate. The concentration of L-arogenate was determined by quantitating the acidified product with respect to a standard curve constructed from authentic Phe.
DEAE-celiulose chromatography. A 193-mg amount of
protein was loaded on a DEAE-cellulose column (2.5 by 23 cm) which was equilibrated with the potassium phosphate extraction-dialysis buffer. The column was washed with 240 ml of equilibration buffer prior to application of a step gradient of 0.12 M KCI in equilibration buffer. Next, three successive linear salt gradients (0.12 to 0.18 M KCI, 400 ml total volume; 0.18 to 0.23 M KCI, 300 ml total volume; and 0.23 to 0.50 M KCI, 600 ml total volume) were applied to the column, followed by a 1 M KCI wash (200 ml) to elute any remaining protein.
Enzyme assays. Prephenate aminotransferase was assayed by HPLC following o-phthalaldehyde derivatization of product formed as described by Bonner and Jensen (9) . The total volume for all aminotransferase reaction mixtures was 100 ,ul. Prephenate aminotransferase activity in crude extracts was determined after incubation at 37°C for 20 min with 50,ul of extract, 20 mM prephenate, and 10 mM indicated amino donor substrate. When L-glutamate was the amino donor, L-arogenate formation (measured as Phe following acidification of the reaction sample) was determined on a C-18 ODS HPLC column (5,um) with a 55% methanol-45% 20 The intracellular pools size of prephenate and L-arogenate were determined after 6 h of accumulation in the tyrAJ9 mutant. The intracellular ratio of L-arogenate to prephenate was 8.0, a striking contrast to the extracellular ratio (Table  1) . Thus, the expandable amino acid (L-arogenate) pool size exceeds the expandable keto acid (prephenate) pool size.
Variations of the accumulation protocol designed to increase the yield or rate of prephenate and/or L-arogenate accumulation in the culture supernatant were ineffective. These variations included provision of shikimate, L-glutamate, L-leucine, and Phe (singly or in combination). These manipulations had also proven to be ineffective in Neurospora crassa (19) .
Prephenate aminotransferase in crude Salmonella extracts. The standard HPLC assay for prephenate aminotransferase in higher plants (9) involves the use of the substrate combination of prephenate and L-glutamate. Although the L-arogenate product coelutes with L-glutamate in the 60% methanolbuffer system used, the L-arogenate product is quantitatively converted to Phe at low pH. The peak area of Phe eluting at 12 min can then be measured without interference from L-glutamate eluting at 3 min. For crude extracts of S. typhimurium, the above assay is, however, seriously complicated by the presence of a very active prephenate dehydratase which (i) competes for the prephenate substrate and (ii) generates phenylpyruvate, which can transaminate with L-glutamate to form Phe. Although the HPLC column conditions can be changed (15% methanol-buffer system) to provide separated eluate peaks of L-glutamate and L-arogenate (thus measuring the L-arogenate product directly), analysis of each sample requires about 40 min (Fig. 2B) .
This problem can be avoided by using Phe in place of L-glutamate as the amino donor substrate in combination with prephenate. Phe was as good as or better than L-glutamate, and the potentially interfering activity of prephenate dehydratase was prevented through the feedback inhibitory effect (100%) of Phe. Thus, relatively rapid assays (about 14 min with a retention time of about 2.3 min for L-arogenate) can be carried out with crude extracts (Fig. 2A) . The specific activity of prephenate aminotransferase when 20 mM prephenate and 10 mM Phe were used was 0.72 nmol min-' mg'1. This is about 25-fold lower than the specific activities characteristic of plant cells (8) . In crude extracts of S. typhimurium, Tyr, L-aspartate, and L-leucine will substitute for Phe as cosubstrates with prephenate to yield 100, 67, and 18%, respectively, of the activity found with Phe.
Whereas prephenate aminotransferase from higher plants saturates at about 0.8 mM prephenate (8, 9) , even 20 mM prephenate was not saturating in S. typhimurium. Figure 3 illustrates this with substrate saturation curves obtained by using either Phe or L-glutamate as the amino donor substrate. It was estimated by extrapolation to Vmax that about 3 Fractionation of aminotransferase activities. DEAE-cellulose (DE52) column chromatography was used to determine whether prephenate aminotransferase activity could be attributed to one or more of the aminotransferases of S. typhimurium corresponding to those that have been so well characterized in E. coli (14, 18) . The elution positions of TRD, TRB, and TRA were readily determined by substrate preferences (Fig. 4A) . The elution position of alanine-valine aminotransferase (TRC) was also determined, but the data are not shown since this enzyme lacked prephenate aminotransferase activity. TRB appeared to be identical. Each of the four aminotransferase activities separated was capable of prephenate transamination, as indicated by the correspondence of peak eluate positions in a comparison of Fig. 4A and B.
Salmonella aminotransferase mutants are not available, but a complete set of E. coli mutants has been isolated and characterized (14) . Mutant constructions possessing only one of the three aminotransferases were analyzed ( Table 2 ). The AspC+ strain possesses a TRA having good activity as a TRD substitute, but not as a TRB substitute. The TyrB+ strain possesses a TRD having significant activity as both TRA and TRB substitutes. The IlvE+ strain possesses a TRB able to function as a TRD substitute but not as a TRA substitute. Each double mutant possesses prephenate ami- (Fig. 4) , except for the presence of a cyclohexadienyl dehydrogenase band at fraction 120. Its profile coincided with a larger peak of CM-T than that shown in Fig. 4 (Fig. 1) scavenged by the prephenate dehydratase or prephenate dehydrogenase components of the P protein or T protein, respectively.
In the tyrAJ9 mutant the potential of CM-F and TRA, TRB, and/or TRD to form L-arogenate is dramatically unmasked. The absence of cyclohexadienyl dehydrogenase (by mutation) and the total feedback inhibition of prephenate dehydratase by exogenous PHE prevent scavenging of prephenate by these enzymes. The unphysiologically high levels of accumulated prephenate would markedly enhance its transamination by TRA, TRB, and/or TRD. The intracellular absence of 4-hydroxyphenylpyruvate or phenylpyruvate (normal keto acid substrates) might maximize the ability of TRD to generate L-arogenate in vivo. Another factor creating bias for TRD transamination of prephenate in vivo is that the protocol of starvation for Tyr which is used in the accumulation protocol derepresses TRD, the gene product of tyrB.
Prephenate can be regarded as a structural analog of 2-ketoglutarate, viewed across the top of the ring (Fig. 1) . Since TRA, TRB, and TRD all transaminate prephenate much more nearly in proportion to their activities with 2-ketoglutarate than with 4-hydroxyphenylpyruvate, it appears that prephenate is accepted as a keto acid analog of 2-ketoglutarate, rather than as an analog of 4-hydroxyphenylpyruvate. Since Salmonella spp. do not coaccumulate spiro-arogenate or prephenyllactate, the formation of these in Neurospora spp. is probably enzymatic. Unless isolation of the latter cyclohexadienyl molecules is desired, the Sal-monella system is preferable for isolation of prephenate or L-arogenate because of technical problems that potentially exist if prephenate or L-arogenate preparations are contaminated with spiro-arogenate or prephenyllactate. For obvious microbiological reasons, the bacterial system is a more efficient source of L-arogenate than is the fungal system. The fortuitous presence of the CM-F isozyme of chorismate mutase in the tyrAJ9 mutant, an evolutionary remnant discarded by E. coli, probably contributes to the excellent accumulation of prephenate in S. typhimurium.
The singular accumulation of prephenate, without conversion to L-arogenate, might be desirable. If so, introduction of multiple deficiencies for ilvE, tyrB, and aspC in the tyrA19 background would apparently be needed to abolish L-arogenate formation entirely. On the other hand, if enhanced L-arogenate production is desired, introduction of an efficient plant-type prephenate aminotransferase (8, 9) into the tyrAJ9 background should vastly increase the ratio of L-arogenate to prephenate in the accumulation medium.
K. pneumoniae lacks CM-F, and therefore the catalytic potential of CDT is functionally isolated in the wild type, owing to the channeling of prephenate molecules generated by CM-P and CM-T. The K. pneumoniae CDT is unusual in its inability to use L-arogenate as a cyclohexadienyl substrate (5) . Mutant 62-1 has a high potential to form Phe, provided an intracellular source of prephenate becomes available. It is quite possible that the well-known high frequency of reversion for the Phe requirement of mutant 62-1 in the presence of Tyr and Trp is due to restored expression of a cryptic gene for CM-F. It can also be appreciated now that it was no accident that in the sequential imposition of mutant blocks in mutant 62-1 (11), the tyrosine block preceded the phenylalanine block. In Klebsiella spp. the pheA deficiency will be masked by the presence of CDT, functioning in concert with the CM-T component of the bifunctional T protein. CM-T, in contrast to the dehydrogenase component, is virtually insensitive to feedback inhibition by L-tyrosine. When the tyrosine deficiency was imposed by Cotton and Gibson (11) via joint loss of the CM-T and dehydrogenase components of the T protein, a genetic background was created whereby a subsequently imposed pheA deficiency no longer exhibited a silent phenotype.
